Evidence map›Paper›PMID 34930367›Full record

ArticleJournal of orthopaedic surgery and research2021

Association among B lymphocyte subset and rheumatoid arthritis in a Chinese population.

Haiyan You, Mengwei Cheng, Cui Ma, Wenjuan Zheng, Yu Jiang, Di Chen, Yu Tang

Open access · goldAbstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Revision surgery for sacral fracture nonunion/delayed union: debridement, autologous graft, and augmented fixation: a 13-case series.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Haiyan YouDepartment of Laboratory Medicine, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
Mengwei ChengDepartment of Rheumatology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
Cui MaDepartment of Rheumatology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
Wenjuan ZhengDepartment of Rheumatology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
Yu JiangDepartment of Rheumatology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
Di ChenDepartment of Rheumatology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
Yu TangDepartment of Rheumatology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China. 1739833926@qq.com.ORCID http://orcid.org/0000-0002-8570-4423
Jiangsu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimAutoantibody production are the main risk factors for inflammation of rheumatoid arthritis (RA). This study aimed to investigate differences in B lymphocyte subsets (native B, memory B, and plasmablasts) and several cytokines in RA patients and their correlation with the clinical parameters.

methodsIn total, 81 RA patients (active RA and inactive RA) and 40 healthy subjects were recruited between September 2018 and October 2020. The distribution of B lymphocyte subsets in peripheral blood samples was measured via flow cytometry and the plasma cytokines were detected by enzyme linked immunosorbent assay. The receiver operating characteristic curve (ROC) was used to evaluate the value of each index for RA diagnosis and activity prediction.

resultsThe percentages of native B and memory B cells in RA patients did not differ significantly from the percentages of those in healthy controls. However, the percentage of plasmablasts in active RA patients was significantly higher compared with healthy subjects and inactive RA patients. The percentage of plasmablasts was significantly related to C reaction protein. ROC curve analysis showed that when the best cutoff value of plasmablasts/B cell was 1.08%, the area under the curve (AUC) for diagnosing RA was 0.831 (95% CI 0.748 ~ 0.915), the specificity was 91.4%, and the sensitivity was 67.5%. The AUC predicted by the combination of plasmablast and anti-CCP for active RA patients was 0.760, which was higher than that of plasmablast and anti-CCP.

conclusionIn conclusion, the percentage of plasmablast varies among RA patients in different stages. The percentage of plasmablasts can be used as an early diagnosis marker for RA.

Indexed as

AdultAgedAnti-Citrullinated Protein AntibodiesArthritis, RheumatoidAsian PeopleBiomarkersB-Lymphocyte SubsetsChinaCytokinesFemaleHumansInflammationMaleMemory B CellsMiddle AgedPeptides, CyclicAnti-Citrullinated Protein AntibodiesBiomarkerscyclic citrullinated peptideCytokinesPeptides, CyclicB lymphocyteChinese populationInflammationRheumatoid arthritis

Identifiers

PMID34930367
PMCPMC8686378
OpenAlexW4226033258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.